[EN] KCNT1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE KCNT1 ET PROCÉDÉS D'UTILISATION
申请人:PRAXIS PREC MEDICINES INC
公开号:WO2020227101A1
公开(公告)日:2020-11-12
The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
[EN] TRIAZOLE OXADIAZOLES DERIVATIVES<br/>[FR] DÉRIVÉS DE TRIAZOLES ET D'OXADIAZOLES
申请人:MERCK SERONO SA
公开号:WO2009080663A1
公开(公告)日:2009-07-02
The invention relates to compounds of formula (I), wherein R1, R2, Ra, Rb, X have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
[EN] HETEROCYCLIC COMPOUNDS AS PESTICIDES<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS EN TANT QUE PESTICIDES
申请人:BAYER AG
公开号:WO2019105875A1
公开(公告)日:2019-06-06
The present application relates to heterocyclic compounds of formula (I), wherein A is phenyl or pyridine, Z is a 5-membered heterocycle and B is pyridine, pyrimidine or pyridazine, as well as compositions containing such compounds, their use for controlling animal pests including arthropods, insects and nematodes, and to processes and intermediates for the preparation of the heterocyclic compounds.
The invention relates to novel heteroaryl-substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular diseases and tumour diseases.